Skip to content

The Effect of Therapeutic Touch and Emotional Freedom Technique on Postpartum Mood and Fatigue in Postpartum Women

The Effect of Therapeutic Touch and Emotional Freedom Technique on Postpartum Mood and Fatigue in Postpartum Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06440109
Enrollment
60
Registered
2024-06-03
Start date
2024-10-01
Completion date
2025-06-10
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotion Regulation, Fatigue

Keywords

emotional freedom technic, therapeutic touch, fatigue, mood state level

Brief summary

Therapeutic touch (TD) is a non-pharmacological/integrated treatment method used to balance the body by regulating the imbalanced energy field in the individual or resolving blockages in energy flow. Emotional freedom technique (EFT) is a psychophysiological intervention that combines elements of somatic stimulation using acupuncture points. This research will be conducted as a randomized controlled experimental study to determine the effect of TD and EFT intervention on postpartum mood and fatigue in postpartum women. This study is planned to be conducted between April 2024 and June 2025 with postpartum women who meet the inclusion criteria and who apply to the Obstetrics and Gynecology Clinic of Necmettin Erbakan University Faculty of Medicine Hospital. This research; It was planned to be carried out with three groups: TD intervention, EFT intervention and control group. The population of the research consists of women who gave birth vaginally and those who gave birth vaginally in the relevant hospital.

Interventions

İntervention groups will be followed for six months and one of the six EFT therapies will be applied, one session every week.

OTHERTherapeutic touch (TD)

İntervention groups will be followed for six weeks and one of the six TD therapies will be applied, one session every week.

Sponsors

KTO Karatay University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Having a vaginal birth at term * Being primiparous * Postpartum 3rd-5th. to be in the days * Being able to speak and understand Turkish * Being 18 years or older * Having a single and viable fetus * Volunteering to participate in research * Not having experienced TD or EFT treatment before

Exclusion criteria

* A psychiatric diagnosis has been made, * Having a chronic systemic disease, * The newborn's need for treatment * Having postpartum complications in the mother or baby * Those who have sensitivity or problems with touch, * Wounds, infections, etc. in places that need to be touched. existence of situations, * Women who have any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish) will be excluded from the research.

Design outcomes

Primary

MeasureTime frameDescription
Postpartum 1rd-5th. EFT intervention will be applied to women who are betweensix weeksSUE scale and vital signs will be taken from the participants before and after each session.
Postpartum 3rd-5th. TD intervention will be applied to women who are betweensix weeksSUE scale and vital signs will be taken from the participants before and after each session.
3rd-5th postpartum Pre- and post-test will be given to women betweensix weeksThe researcher will not perform any intervention on women in this group. After the pre-tests are completed, women in this group will be called by phone during the interview weeks for the intervention group, their postpartum needs will be questioned and support will be provided when necessary. The implementation of the final tests will be completed in the sixth week.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026